BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37070619)

  • 1. Frequency of superscan on bone scintigraphy: A systematic review.
    Kovacsne A; Kozon I; Bentestuen M; Zacho HD
    Clin Physiol Funct Imaging; 2023 Sep; 43(5):297-304. PubMed ID: 37070619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical note: identifying the prostate cancer 'superscan' by quantitative skeletal scintigraphy.
    Hawkins T; Halewood MM
    Nucl Med Commun; 2008 Jul; 29(7):654-9. PubMed ID: 18528189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic superscan on (99m)Tc-MDP bone scintigraphy in a case of carcinoma colon: Common finding but rare etiology.
    Chakraborty PS; Sharma P; Karunanithi S; Bal C; Kumar R
    Indian J Nucl Med; 2014 Jul; 29(3):158-9. PubMed ID: 25210281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistent Superscan and Lincoln Sign on Bone Scintigraphy.
    Kulkarni M; Soni A; Shetkar S; Amer M; Mulavekar A; Joshi P
    Clin Nucl Med; 2017 Aug; 42(8):630-632. PubMed ID: 28525460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?
    Simsek DH; Sanli Y; Civan C; Engin MN; Isik EG; Ozkan ZG; Kuyumcu S
    Ann Nucl Med; 2020 Jul; 34(7):476-485. PubMed ID: 32394269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic superscan on (99m)Tc-methylene diphosphonate bone scintigraphy in pediatric neuroblastoma.
    Arora S; Dhull VS; Mukherjee A; Tulsyan S; Behera A; Tripathi M
    Indian J Nucl Med; 2015; 30(3):286-7. PubMed ID: 26170581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superscan on Methylene Diphosphonate Skeletal Scintigraphy in Prostatic Adenocarcinoma: A Common Finding but Rare Etiology.
    Chatterjee P; Mukherjee A; Mitra D; Nautiyal A; Roy A
    Indian J Nucl Med; 2017; 32(4):369-371. PubMed ID: 29142365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy.
    Yüksel D; Ilgan S; Arslan N; Uğur O; Oztürk E; Bayhan H
    Clin Nucl Med; 2000 Mar; 25(3):193-6. PubMed ID: 10698416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superscan in patients with nasopharyngeal carcinoma.
    Liu RS; Chu YK; Chu LS; Yeh SH; Yen SH; Chen KY; Chen YK; Shen YY
    Clin Nucl Med; 1996 Apr; 21(4):302-6. PubMed ID: 8925613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of the superscan in prostatic bone scintigraphy.
    Constable AR; Cranage RW
    Br J Radiol; 1981 Feb; 54(638):122-5. PubMed ID: 7459549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of a computer-assisted diagnosis system for bone scintigraphy of newly developed skeletal metastasis in prostate cancer patients: search for low-sensitivity subgroups.
    Koizumi M; Motegi K; Koyama M; Terauchi T; Yuasa T; Yonese J
    Ann Nucl Med; 2017 Aug; 31(7):521-528. PubMed ID: 28456877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Super-superscan on a bone scintigraphy.
    Liu Y
    Clin Nucl Med; 2011 Mar; 36(3):227-8. PubMed ID: 21285685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc bone scintigraphy superscans: a review.
    Buckley O; O'Keeffe S; Geoghegan T; Lyburn ID; Munk PL; Worsley D; Torreggiani WC
    Nucl Med Commun; 2007 Jul; 28(7):521-7. PubMed ID: 17538392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of discrete sacral foramina as an ancillary sign of superscan.
    Harshman LK; Latifi HR; Griffeth LK
    Clin Nucl Med; 2011 Jan; 36(1):21-4. PubMed ID: 21157202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
    Weckesser M; Müller-Mattheis VG; Vosberg H; Müller-Gärtner HW
    Nuklearmedizin; 1998 Jun; 37(4):156-8. PubMed ID: 9650218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observer agreement and accuracy in the evaluation of bone scans in newly diagnosed prostate cancer.
    Zacho HD; Manresa JA; Mortensen JC; Bertelsen H; Petersen LJ
    Nucl Med Commun; 2015 May; 36(5):445-51. PubMed ID: 25646705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.
    KandaSwamy GV; Bennett A; Narahari K; Hughes O; Rees J; Kynaston H
    BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of a computer-assisted diagnostic system: sensitivity of BONENAVI for bone scintigraphy in patients with disseminated skeletal metastasis is not so high.
    Koizumi M; Motegi K; Koyama M; Ishiyama M; Togawa T; Makino T; Arisaka Y; Terauchi T
    Ann Nucl Med; 2020 Mar; 34(3):200-211. PubMed ID: 31970706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal Metastases Presenting as Superscan on Technetium 99m Methylene Diphosphonate Whole Body Bone Scintigraphy in Different Type of Cancers: A 5-Year Retro-prospective Study.
    Manohar PR; Rather TA; Khan SH; Malik D
    World J Nucl Med; 2017; 16(1):39-44. PubMed ID: 28217018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.